Observational Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026 [Associations of candidate gene polymorphisms, gut microbiota, and their interactions with NAFLD in obese children]. Wei C, Pan X, Liu Y, et al. Bacteroides PubMed ↗
Review FASEB journal · 2026 The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease: From Mechanistic Insights to Precision Therapeutics. Zhu S, Zou M, Wu Q, et al. Akkermansia muciniphila PubMed ↗
Systematic review Current obesity reports · 2026 The Role of Butyrate in People with Metabolic Dysfunction-Associated Steatotic Liver Disease and Related Metabolic Comorbidities: A Systematic Review. González-González A, Soria-Utrilla V, Fontalba-Romero MI, et al. Faecalibacterium prausnitzii PubMed ↗
Observational BMC microbiology · 2025 High alcohol-producing Escherichia coli causes obesity and steatotic liver disease in a non-alcoholic cohort -a preclinical study. Singh A, Singh DN, Singh AN, et al. Escherichia coli PubMed ↗
Observational Journal of translational medicine · 2025 Characterization of the gut virome in patients with nonalcoholic fatty liver disease. Wang L, Wang L, Liu M, et al. Faecalibacterium PubMed ↗
Systematic review BMC gastroenterology · 2025 Therapeutic potential of Akkermansia muciniphila in non-alcoholic fatty liver disease: a systematic review. Asghari P, Ahmadi-Khorram M, Hatami A, et al. Akkermansia muciniphila PubMed ↗
Randomized trial Journal of agricultural and food chemistry · 2025 Hydroxytyrosol Improves Metabolic Dysfunction-Associated Fatty Liver Disease Dependent on the Modulation of Gut Microbiota. Xiao Y, Zhang X, Shao B, et al. Fusicatenibacter saccharivorans PubMed ↗
Observational mSystems · 2025 Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease. Du L, Zhang K, Liang L, et al. [Ruminococcus] torques PubMed ↗
Review Iranian biomedical journal · 2025 Role of Gut-Liver Axis in Non-Alcoholic Fatty Liver Disease. Yaghmaei H, Taromiha A, Nojoumi SA, et al. Faecalibacterium PubMed ↗
Observational Environmental health and preventive medicine · 2025 A 4-year cohort study of the effects of PNPLA3 rs738409 genotypes on liver fat and fibrosis and gut microbiota in a non-fatty liver population. Sato S, Iino C, Sasada T, et al. Blautia PubMed ↗
Review Probiotics and antimicrobial proteins · 2024 Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics. Singh V, Mahra K, Jung D, et al. Faecalibacterium PubMed ↗
Meta-analysis PloS one · 2024 Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis. Cai W, Qiu T, Hu W, et al. Faecalibacterium PubMed ↗
Observational Atherosclerosis · 2024 A universal plasma metabolites-derived signature predicts cardiovascular disease risk in MAFLD. Li Z, Gong R, Chu H, et al. Faecalibacterium PubMed ↗
Review Current nutrition reports · 2024 The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence. Vallianou NG, Kounatidis D, Psallida S, et al. Akkermansia muciniphilaFaecalibacterium prausnitzii PubMed ↗
Review Hepatology communications · 2024 Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease. Long Q, Luo F, Li B, et al. Akkermansia muciniphilaFaecalibacterium PubMed ↗
Randomized trial Romanian journal of internal medicine = Revue roumaine de medecine interne · 2024 The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial. Mitrović M, Dobrosavljević A, Odanović O, et al. Faecalibacterium PubMed ↗
Review Bioorganic chemistry · 2024 Effects of selenium nanoparticles produced by Lactobacillus acidophilus HN23 on lipid deposition in WRL68 cells. Lei X, Peng Y, Li Y, et al. Lactobacillus acidophilus PubMed ↗
Review Archives of microbiology · 2024 Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets. Gruzdev SK, Podoprigora IV, Gizinger OA Escherichia coliKlebsiella pneumoniae PubMed ↗
Observational Wiadomosci lekarskie · 2024 Differentiated approach to management of patients with irritable bowel syndrome and ulcerative colitis in non-alcoholic fatty liver disease. Sirchak YS, Kornash VV, Dutko OO, et al. Escherichia coli PubMed ↗
Randomized trial The American journal of clinical nutrition · 2023 Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. Chooi YC, Zhang QA, Magkos F, et al. Bifidobacterium adolescentis PubMed ↗
Randomized trial Cell metabolism · 2023 Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations. Ni Y, Qian L, Siliceo SL, et al. Bacteroides stercoris PubMed ↗
Review Pharmacological research · 2023 Gut mycobiome and metabolic diseases: The known, the unknown, and the future. Wang L, Zhang K, Zeng Y, et al. Saccharomyces cerevisiae PubMed ↗
Randomized trial The Journal of nutrition · 2023 Probiotic Supplementation, Hepatic Fibrosis, and the Microbiota Profile in Patients with Nonalcoholic Steatohepatitis: A Randomized Controlled Trial. Escouto GS, Port GZ, Tovo CV, et al. Bifidobacterium animalisLactobacillus acidophilus PubMed ↗
Clinical trial Gut microbes · 2023 Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis. Gómez-Pérez AM, Ruiz-Limón P, Salas-Salvadó J, et al. BlautiaFaecalibacterium PubMed ↗
Observational PloS one · 2022 Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study. Tateda T, Iino C, Sasada T, et al. Blautia PubMed ↗
Review Frontiers of medicine · 2022 Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives. Han Y, Li L, Wang B Akkermansia muciniphila PubMed ↗
Randomized trial Annals of hepatology · 2022 Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study. Barcelos STA, Silva-Sperb AS, Moraes HA, et al. Bifidobacterium animalisLacticaseibacillus paracaseiLacticaseibacillus rhamnosusLactobacillus acidophilus PubMed ↗
Meta-analysis Journal of pediatric gastroenterology and nutrition · 2022 The Benefit of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: A Meta-analysis of Randomized Control Trials. Gkiourtzis Ν, Kalopitas G, Vadarlis A, et al. Lactobacillus acidophilus PubMed ↗
Randomized trial The American journal of gastroenterology · 2022 A Freshwater Fish-Based Diet Alleviates Liver Steatosis by Modulating Gut Microbiota and Metabolites: A Clinical Randomized Controlled Trial in Chinese Participants With Nonalcoholic Fatty Liver Disease. He K, Guo LL, Tang H, et al. Faecalibacterium PubMed ↗
Randomized trial Cellular and molecular biology · 2022 Effects of Clostridium butyricum Capsules Combined with Rosuvastatin on Intestinal Flora, Lipid Metabolism, Liver Function and Inflammation in NAFLD Patients. Zhu W, Yan M, Cao H, et al. Clostridium butyricumAgathobacter rectalisBacteroides thetaiotaomicron PubMed ↗
Review Obesity reviews · 2022 Human microbiome and metabolic health: An overview of systematic reviews. Michels N, Zouiouich S, Vanderbauwhede B, et al. Akkermansia muciniphilaBacteroides fragilisBifidobacterium animalisLactiplantibacillus plantarum +3 more PubMed ↗
Observational AIDS · 2022 A pilot study of microbial signatures of liver disease in those with HIV mono-infection in Rio de Janeiro, Brazil. Yanavich C, Perazzo H, Li F, et al. Agathobacter rectalisAkkermansia muciniphilaBacteroides fragilisBacteroides stercoris +5 more PubMed ↗
Review Biomolecules · 2021 Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Vallianou N, Christodoulatos GS, Karampela I, et al. Akkermansia muciniphilaFaecalibacterium prausnitziiSegatella copriBlautia PubMed ↗
Observational Frontiers in cellular and infection microbiology · 2021 Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease. Pan X, Kaminga AC, Liu A, et al. Faecalibacterium PubMed ↗
Observational Physiological genomics · 2021 Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD. Jiao N, Loomba R, Yang ZH, et al. Bacteroides ovatus PubMed ↗
Observational Liver international · 2021 Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease. Lang S, Martin A, Zhang X, et al. Faecalibacterium PubMed ↗
Systematic review United European gastroenterology journal · 2021 Gut fermentation syndrome: A systematic review of case reports. Bayoumy AB, Mulder CJJ, Mol JJ, et al. Klebsiella pneumoniaeSaccharomyces cerevisiae PubMed ↗
Meta-analysis Lipids in health and disease · 2021 Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis. Li F, Ye J, Shao C, et al. BacteroidesBlautiaFaecalibacterium PubMed ↗
International immunopharmacology · 2026 Curdlan alleviates non-alcoholic fatty liver disease by enriching butyrate-producing gut microbiota-liver axis. Yang X, Zeng F, Xu J, et al. Clostridium butyricum PubMed ↗
BMC gastroenterology · 2026 Short-term synbiotic supplementation and intrahepatic triglyceride content assessed by proton MR spectroscopy: a pilot study. Genc O, Klisic A, Stevuljevic JK, et al. Bifidobacterium animalisLactobacillus acidophilus PubMed ↗
Journal of agricultural and food chemistry · 2026 UPLC-Q-TOF/MS-Based Metabolomics and 16S rRNA Profiling Reveal that Corosolic Acid Ameliorates High-Fat Diet-Induced MASLD by Modulating the Gut-Liver Axis to Inhibit the cGAS-STING Pathway. Cai K, Chen Z, Deng S, et al. Blautia PubMed ↗
Arab journal of gastroenterology · 2026 Clinical efficacy of Jiawei Yinchenhao decoction combined with ursodeoxycholic acid and probiotics in the management of nonalcoholic fatty liver disease. Chen D, Li X, Fu J, et al. Escherichia coli PubMed ↗
Gut microbes · 2026 Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translation. Benedé-Ubieto R, Estévez-Vázquez O, Acar R, et al. Bacteroides PubMed ↗
Molecular nutrition & food research · 2026 Oxidative Balance Score, Genetic Predictors of the Gut Microbiome, and the Risk of Metabolic-Associated Fatty Liver Disease: A Cohort Study. Ji X, Wang Y, Li L, et al. [Ruminococcus] torques PubMed ↗
Cellular and molecular gastroenterology and hepatology · 2025 Probiotics Mitigate High-cholesterol Diet-driven Fatty Liver and Pancreatic Cancer by Restoring Macrophage Homeostasis. Parida D, Mishra S, Mohapatra AP, et al. Lacticaseibacillus rhamnosusLactiplantibacillus plantarum PubMed ↗
Antonie van Leeuwenhoek · 2025 The discovery, probiotic properties, and genome analysis of Lactiplantibacillus plantarum HP-B1280 with potential therapeutic application for the treatment of non-alcoholic fatty liver disease. Liu WC, Liu MJ, Jiang JX, et al. Lactiplantibacillus plantarum PubMed ↗
Journal of ethnopharmacology · 2025 Eucommia alleviates high fat diet-induced MASLD via the F. prausnitzii/butyrate/GPR43/GLP-1 signaling. Wang Z, Zhu Y, Wang G, et al. Faecalibacterium prausnitzii PubMed ↗
Journal of medicinal food · 2025 Bacillus subtilis pb2441 Ameliorates Hepatic Steatosis by Decoupling Liver and Fat Tissue Lipid Accumulation in a High-Fat Diet-Fed Mouse Model. Lee JY, Park SS, Cho IK, et al. Bacillus subtilis PubMed ↗
Frontiers in immunology · 2025 Lactobacillus salivarius extracellular vesicles enhance gut and liver function in MAFLD. Zhu L, Huang J, Luo Z, et al. Ligilactobacillus salivarius PubMed ↗
Nutrition journal · 2025 Development and validation of a multimodal model integrating gut microbiota and metabolite for identifying sarcopenia in patients with MASLD: a study from two centers in China. Wan S, Li M, Li W, et al. Enterococcus faeciumPhocaeicola vulgatus PubMed ↗